NEW YORK, NY / ACCESS Newswire / March 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...
NEW YORK, NY / ACCESS Newswire / March 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...
Highlights,Smartleaf Asset Management LLC increased its stake in Supernus Pharmaceuticals, reflecting growing institutional activity.,Several financial firms, including Janney Montgomery Scott LLC and ...
Supernus' neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in Parkinson’s disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients ...
Explore Supernus Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SUPN. Supernus' SPN-820 Phase 2b study in treatment-resistant depression ...
On Tuesday, 11 March 2025, Supernus Pharmaceuticals (NASDAQ: SUPN) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic direction and financial performance. The ...
This guide covers all the logo design rules, best practices, tips, examples, and more to equip you with the knowledge for crafting brilliant logos. Logos are one of the most vital elements of any ...
AN eye clinic is now open at the Metoreia Health Centre in the National Capital District.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
